Action Alert

Dear KOL –

I am writing to solicit your help with an issue that is very important to me personally, and to the National Minority Quality Forum (NMQF) as an institution. I am asking you to consider submitting a public comment to the National Quality Forum (NQF) by August 12 in support of the NMQF submission for a new quality measure for self-identified blacks with Heart Failure (HF).

Two weeks ago, we submitted a proposed, but long overdue, quality measure to NQF to reflect the appropriate standard of care for African Americans with Heart Failure. As many in our community are aware, today, only a very small number (about 7%) of African Americans who are clinical eligible for the FDA-approved therapy are getting it. As a consequence, over 6,500 blacks die prematurely every year because they are not receiving or adhering to standard of care.  This situation must be addressed.

The quality measure submission advanced by the National Minority Quality Forum would act to strongly encourage healthcare providers to ensure that eligible African American patients with heart disease receive the proper course of care treatment – namely, fixed-dose hydralazine and isosorbide dinitrate. The benefits of this FDA-approved treatment have been published in the New England Journal of Medicineand other peer-reviewed sources. Moreover, this proposal is based on an American College of Cardiology/American Heart Association guideline calling for this specific treatment protocol.

The NQF’s determination regarding the merits of our submission will be substantially influenced by public input, and especially informed members of the public, like you, can play a critical role in impacting their decision. Accordingly, I hope you will take the time to submit a comment in support of this important initiative.

In order to better familiarize you with the issue, I am attaching a fact sheet for your review. Additionally, in order to facilitate your commenting, I have included instructions below on how to submit to the NQF.

Thank you, again, for your consideration of this request for assistance. With your help, and the engagement of others like you, we can advance an important improvement in the care of African Americans with Heart Failure, and show progress towards eradicating this terrible disparity in our healthcare system.

Thank You,

Gary A. Puckrein, PhD
President and Chief Executive Officer



How to comment:


1. Click here to create an account with the National Quality Forum (NQF)

a. Provide your name and contact information in steps 1 and 2

b. Activate your account by following the link included in the confirmation email provided by NQF

c. Select a username and password, then click submit


2. Click here to log in to NQFs online comment portal for cardiovascular measures

a. Log in using your NQF username and password

b. Identify the comment titled NQF# 2764 – Fixed-dose Combination of Hydralazine and Isosorbide Dinitrate Therapy for Self-identified Black or African American Patients with Heart Failure and LVEF <40% on ACEI or ARB and Beta-blocker Therapy  (As of July 27, this is the last entry on pg. 3 of the cardiovascular measures)


3.  Click ‘Comment’ to open the submission window for the relevant heart failure quality measure

a. Enter the text of your submission in the comment window

b. At the bottom of the submission form, click ‘Submit Comment’